We are pleased to invite you to read the Highly Cited papers in 2023 in Cancers (ISSN: 2072-6694) in Section “Cancer Biomarkers”. We hope this announcement will provide useful information for this field.

The papers list is as follows:

“Extracellular Vesicles in Liquid Biopsies as Biomarkers for Solid Tumors”
by Barnabas Irmer, Suganja Chandrabalan, Lukas Maas, Annalen Bleckmann and Kerstin Menck
Cancers 2023, 15(4), 1307; https://doi.org/10.3390/cancers15041307
Available online: https://www.mdpi.com/2072-6694/15/4/1307

“Liquid Biopsies, Novel Approaches and Future Directions”
by Athanasios Armakolas, Maria Kotsari and John Koskinas
Cancers 2023, 15(5), 1579; https://doi.org/10.3390/cancers15051579
Available online: https://www.mdpi.com/2072-6694/15/5/1579

“Potential Impact of PI3K-AKT Signaling Pathway Genes, KLF-14, MDM4, miRNAs 27a, miRNA-196a Genetic Alterations in the Predisposition and Progression of Breast Cancer Patients”
by Othman R. Alzahrani, Rashid Mir, Hanan E. Alatwi, Yousef M. Hawsawi, Amnah A. Alharbi, Abdulrahman H. Alessa, Elham Saleh Albalawi, Imadeldin Elfaki, Yousef Alalawi, Laila Moharam et al.
Cancers 2023, 15(4), 1281; https://doi.org/10.3390/cancers15041281
Available online: https://www.mdpi.com/2072-6694/15/4/1281

“Classification of Chondrosarcoma: From Characteristic to Challenging Imaging Findings”
by Jun-Ho Kim and Seul Ki Lee
Cancers 2023, 15(6), 1703; https://doi.org/10.3390/cancers15061703
Available online: https://www.mdpi.com/2072-6694/15/6/1703

“Probing the Potential of Defense Response-Associated Genes for Predicting the Progression, Prognosis and Immune Microenvironment of Osteosarcoma”
by Liangkun Huang, Fei Sun, Zilin Liu, Wenyi Jin, Yubiao Zhang, Junwen Chen, Changheng Zhong, Wanting Liang and Hao Peng
Cancers 2023, 15(8), 2405; https://doi.org/10.3390/cancers15082405
Available online: https://www.mdpi.com/2072-6694/15/8/2405

“Exosomes as a Source of Biomarkers for Gastrointestinal Cancers”
by Jingjing Yu, Arsha Ostowari, Amber Gonda, Kiarash Mashayekhi, Farshid Dayyani, Christopher C. W. Hughes and Maheswari Senthil
Cancers 2023, 15(4), 1263; https://doi.org/10.3390/cancers15041263
Available online: https://www.mdpi.com/2072-6694/15/4/1263

“Dominant Gene Expression Profiles Define Adenoid Cystic Carcinoma (ACC) from Different Tissues: Validation of a Gene Signature Classifier for Poor Survival in Salivary Gland ACC”
by Kathryn J. Brayer, Huining Kang, Adel K. El-Naggar, Simon Andreasen, Preben Homøe, Katalin Kiss, Lauge Mikkelsen, Steffen Heegaard, Daniel Pelaez, Acadia Moeyersoms et al.
Cancers 2023, 15(5), 1390; https://doi.org/10.3390/cancers15051390
Available online: https://www.mdpi.com/2072-6694/15/5/1390

“Comparison of Four Albumin-Based Liver Reserve Models (ALBI/EZ-ALBI/PALBI/PAL) against MELD for Patients with Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization”
by Shu-Yein Ho, Po-Hong Liu, Chia-Yang Hsu, Yi-Hsiang Huang, Jia-I Liao, Chien-Wei Su, Ming-Chih Hou and Teh-Ia Huo
Cancers 2023, 15(7), 1925; https://doi.org/10.3390/cancers15071925
Available online: https://www.mdpi.com/2072-6694/15/7/1925

“Design and Biological Evaluation of Small-Molecule PET-Tracers for Imaging of Programmed Death Ligand 1”
by Fabian Krutzek, Cornelius K. Donat, Martin Ullrich, Kristof Zarschler, Marie-Charlotte Ludik, Anja Feldmann, Liliana R. Loureiro, Klaus Kopka and Sven Stadlbauer
Cancers 2023, 15(9), 2638; https://doi.org/10.3390/cancers15092638
Available online: https://www.mdpi.com/2072-6694/15/9/2638

“STARD3: A New Biomarker in HER2-Positive Breast Cancer”
by Massimo Lodi, Laetitia Voilquin, Fabien Alpy, Sébastien Molière, Nathalie Reix, Carole Mathelin, Marie-Pierrette Chenard and Catherine-Laure Tomasetto
Cancers 2023, 15(2), 362; https://doi.org/10.3390/cancers15020362
Available online: https://www.mdpi.com/2072-6694/15/2/362

You are invited to view and submit relevant papers to the journal Cancers.

Cancers Editorial Office